-
Mashup Score: 4Efficacy and Safety of Tofacitinib in Anti–Melanoma... : JCR: Journal of Clinical Rheumatology - 4 month(s) ago
were treated with tofacitinib and followed up. Clinical and laboratory data of these patients were recorded between January 2019 and June 2022. SPSS was used for all statistical analyses. Results The mean age of patients with MDA5+DM was 45 ± 12.4 years, and the median disease duration was 6.5 months (range, 3–13 months). The mean dosage of glucocorticoids was 34.7 ± 20.9 mg/d at the initiation of tofacitinib therapy. Overall, 47 patients were followed up for a mean duration of 7.8 ± 6.2 months. We found that the clinical symptoms of 28 patients (59.6%) were improved, but 1 patient (2.1%) died because of severe infection. Moreover, complications occurred in 25 patients (53.2%), among whom 19 patients had infections. Older age and C-reactive protein levels close to the upper value in reference range at the initial treatment were found to be the potential risk factors of infection. Furthermore, patients with cutaneous ulcers were found to have a lower risk of infection. Conclusion Tofaci
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0
Only 10% of providers surveyed follow the American College of Rheumatology criteria for fibromyalgia.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Only 10% of providers surveyed follow the American College of Rheumatology criteria for fibromyalgia.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2TENS Treatment Improves Pressure Pain Thresholds in Fibromyalgia - 4 month(s) ago
Results indicate the potential relevance of pressure pain thresholds for understanding the mechanisms that contribute to pain in fibromyalgia.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2TENS Treatment Improves Pressure Pain Thresholds in Fibromyalgia - 4 month(s) ago
Results indicate the potential relevance of pressure pain thresholds for understanding the mechanisms that contribute to pain in fibromyalgia.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0Enrollment of Minorities in Fibromyalgia Trials Remains Low - 4 month(s) ago
Among the fibromyalgia studies conducted in the US and Canada over the past 22 years, 90% of participants identified as White.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Enrollment of Minorities in Fibromyalgia Trials Remains Low - 4 month(s) ago
Among the fibromyalgia studies conducted in the US and Canada over the past 22 years, 90% of participants identified as White.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Enrollment of Minorities in Fibromyalgia Trials Remains Low - 4 month(s) ago
Among the fibromyalgia studies conducted in the US and Canada over the past 22 years, 90% of participants identified as White.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Future Developments in Fibromyalgia Treatment - 4 month(s) ago
Philip J. Mease, MD, highlights the potential of blood biomarkers to assist with diagnosing fibromyalgia, as well as other imaging modalities.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5
Neuroinflammation expert Jarred Younger, PhD, disputes commentary calling for clinicians to stop prescribing the off-label compounded medication to reduce pain in people with fibromyalgia.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
👉The Vast Majority of Patients With #Fibromyalgia Have a Straight Neck Observed on a Lateral View Radiograph of the Cervical Spine. https://t.co/D5R6QATW1f https://t.co/l7NKrFPHUY